The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Epidemiology of epithelial ovarian cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
Calle, E. E., & Kaaks, R. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1408 · Cited by 3,613
Armstrong, B., & Doll, R. (1975) · International Journal of Cancer · doi:10.1002/ijc.2910150411 · Cited by 2,151
Association of Leisure-Time Physical Activity With Risk of 26 Types of Cancer in 1.44 Million Adults
Moore, S. C., Lee, I.-M., Weiderpass, E., Campbell, P. T., Sampson, J. N., Kitahara, C. M., Keadle, S. K., Arem, H., Berrington de Gonzalez, A., Hartge, P., et al. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.1548 · Cited by 1,487
Alsop, K., Fereday, S., Meldrum, C., deFazio, A., Emmanuel, C., George, J., Dobrovic, A., Birrer, M. J., Webb, P. M., Stewart, C., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.8545 · Cited by 1,180
Self-citationINCESSANT OVULATION—A FACTOR IN OVARIAN NEOPLASIA ?
Fathalla, M. F. (1971) · The Lancet · doi:10.1016/s0140-6736(71)92335-x · Cited by 1,119
Whittmore, A. S., Harris, R., & Itnyre, J. (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116427 · Cited by 1,000
Pearce, C. L., Templeman, C., Rossing, M. A., Lee, A., Near, A. M., Webb, P. M., Nagle, C. M., Doherty, J. A., Cushing-Haugen, K. L., Wicklund, K. G., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70404-1 · Cited by 939
Self-citationInhibition of Carcinogenesis by Tea
Yang, C. S., Maliakal, P., & Meng, X. (2002) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.082101.154309 · Cited by 939
Type I and II Endometrial Cancers: Have They Different Risk Factors?
Setiawan, V. W., Yang, H. P., Pike, M. C., McCann, S. E., Yu, H., Xiang, Y.-B., Wolk, A., Wentzensen, N., Weiss, N. S., Webb, P. M., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.48.2596 · Cited by 827
Self-citationCollaborative Group on Epidemiological Studies of Ovarian Cancer (2008) · The Lancet · doi:10.1016/s0140-6736(08)60167-1 · Cited by 822
Risch, H. A. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.23.1774 · Cited by 771
Parkin, D. M., Boyd, L., & Walker, L. C. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.489 · Cited by 663
Possible Role of Ovarian Epithelial Inflammation in Ovarian Cancer
Ness, R. B., & Cottreau, C. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.17.1459 · Cited by 588
Determinants of Ovarian Cancer Risk. II. Inferences Regarding Pathogenesis 2
(1983) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/71.4.717 · Cited by 535
Ip, S., Chung, M., Raman, G., Trikalinos, T. A., & Lau, J. (2009) · Breastfeeding Medicine · doi:10.1089/bfm.2009.0050 · Cited by 529
Rose, D. P., Boyar, A. P., & Wynder, E. L. (1986) · Cancer · doi:10.1002/1097-0142(19861201)58:11<2363::aid-cncr2820581102>3.0.co;2-# · Cited by 518
Wentzensen, N., Poole, E. M., Trabert, B., White, E., Arslan, A. A., Patel, A. V., Setiawan, V. W., Visvanathan, K., Weiderpass, E., Adami, H.-O., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.66.8178 · Cited by 514
Collaborative Group on Epidemiological Studies of Ovarian Cancer (2015) · The Lancet · doi:10.1016/s0140-6736(14)61687-1 · Cited by 472
Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer
Ramus, S. J., Song, H., Dicks, E., Tyrer, J. P., Rosenthal, A. N., Intermaggio, M. P., Fraser, L., Gentry-Maharaj, A., Hayward, J., Philpott, S., et al. (2015) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djv214 · Cited by 437
Infertility, Fertility Drugs, and Ovarian Cancer: A Pooled Analysis of Case-Control Studies
Ness, R. B. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.3.217 · Cited by 422
Endogenous Hormones and Breast Cancer Collaborative Group (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.254 · Cited by 391
Risk of cancer after use of fertility drugs with in-vitro fertilisation
Venn, A., Watson, L., Bruinsma, F., Giles, G., & Healy, D. (1999) · The Lancet · doi:10.1016/s0140-6736(99)05203-4 · Cited by 371
The Reduction in Risk of Ovarian Cancer Associated with Oral-Contraceptive Use
The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development* (1987) · New England Journal of Medicine · doi:10.1056/nejm198703123161102 · Cited by 365
Song, H., Dicks, E., Ramus, S. J., Tyrer, J. P., Intermaggio, M. P., Hayward, J., Edlund, C. K., Conti, D., Harrington, P., Fraser, L., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.2408 · Cited by 328
Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: A meta-analysis
Iodice, S., Barile, M., Rotmensz, N., Feroce, I., Bonanni, B., Radice, P., Bernard, L., Maisonneuve, P., & Gandini, S. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.04.018 · Cited by 281
The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010
Peto, R. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.473 · Cited by 265
(2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70322-4 · Cited by 249
Trabert, B., Ness, R. B., Lo-Ciganic, W.-H., Murphy, M. A., Goode, E. L., Poole, E. M., Brinton, L. A., Webb, P. M., Nagle, C. M., Jordan, S. J., et al. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt431 · Cited by 243
Self-citationA systematic review and meta‐analysis of family history and risk of ovarian cancer
Stratton, J. F., Pharoah, P., Smith, S. K., Easton, D., & Ponder, B. A. J. (1998) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1998.tb10148.x · Cited by 239
Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium
Olsen, C. M., Nagle, C. M., Whiteman, D. C., Ness, R., Pearce, C. L., Pike, M. C., Rossing, M. A., Terry, K. L., Wu, A. H., _, _., et al. (2013) · Endocrine-Related Cancer · doi:10.1530/erc-12-0395 · Cited by 234
Self-citationCollaborative Group on Epidemiological Studies of Ovarian Cancer (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001200 · Cited by 225
The Reduction in Risk of Ovarian Cancer Associated with Oral-Contraceptive Use
LEE, N. C., WINGO, P. A., GWINN, M. L., RUBIN, G. L., KENDRICK, J. S., WEBSTER, L. A., & ORY, H. W. (1987) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198710000-00016 · Cited by 217
Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies
Sieh, W., Salvador, S., McGuire, V., Weber, R. P., Terry, K. L., Rossing, M. A., Risch, H., Wu, A. H., Webb, P. M., Moysich, K., et al. (2013) · International Journal of Epidemiology · doi:10.1093/ije/dyt042 · Cited by 170
Self-citationRisk of cancer among women with polycystic ovary syndrome: A Danish cohort study
Gottschau, M., Kjaer, S. K., Jensen, A., Munk, C., & Mellemkjaer, L. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.11.012 · Cited by 166
Breastfeeding and ovarian cancer risk: a meta-analysis of epidemiologic studies
Luan, N.-N., Wu, Q.-J., Gong, T.-T., Vogtmann, E., Wang, Y.-L., & Lin, B. (2013) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.062794 · Cited by 159
Use of metformin and the risk of ovarian cancer: A case–control analysis
Bodmer, M., Becker, C., Meier, C., Jick, S. S., & Meier, C. R. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.06.038 · Cited by 159
Antoniou, A. C., Rookus, M. A., Andrieu, N., Brohet, R. M., Chang-Claude, J. C., Peock, S., Cook, M., Evans, D. G., Eeles, R. A., EMBRACE, et al. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0546 · Cited by 157
Age at menarche and risk of ovarian cancer: A meta‐analysis of epidemiological studies
Gong, T., Wu, Q., Vogtmann, E., Lin, B., & Wang, Y. (2012) · International Journal of Cancer · doi:10.1002/ijc.27952 · Cited by 157
Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study
Ong, J., Cuéllar-Partida, G., Lu, Y., Study, A. O. C., Fasching, P. A., Hein, A., Burghaus, S., Beckmann, M. W., Lambrechts, D., Nieuwenhuysen, E. V., et al. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw207 · Cited by 150
Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility
Rizzuto, I., Behrens, R. F., & Smith, L. A. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008215.pub2 · Cited by 148
Use of fertility drugs and risk of ovarian cancer: Danish population based cohort study
Jensen, A., Sharif, H., Frederiksen, K., & Kjær, S. K. (2009) · BMJ · doi:10.1136/bmj.b249 · Cited by 147
Urban, M. I., Banks, E., Egger, S. J., Canfell, K., O’Connell, D. L., Beral, V., & Sitas, F. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001182 · Cited by 147
Tea consumption and ovarian cancer risk: a case-control study in China.
Zhang, M., Binns, C. W., & Lee, A. H. (2002) · PubMed · Cited by 129
Dairy Products and Ovarian Cancer: A Pooled Analysis of 12 Cohort Studies
Genkinger, J. M., Hunter, D. J., Spiegelman, D. L., Anderson, K. E., Arslan, A. A., Beeson, W. L., Buring, J. E., Fraser, G. E., Freudenheim, J. L., Goldbohm, R. A., et al. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0484 · Cited by 122
Cancers in Australia in 2010 attributable to modifiable factors: summary and conclusions
Whiteman, D. C., Webb, P. M., Green, A. C., Neale, R. Ε., Fritschi, L., Bain, C. J., Parkin, D. M., Wilson, L. F., Olsen, C. M., Nagle, C. M., et al. (2015) · Australian and New Zealand Journal of Public Health · doi:10.1111/1753-6405.12471 · Cited by 121
Self-citationPearce, C. L., Chung, K., Pike, M. C., & Wu, A. H. (2009) · Cancer · doi:10.1002/cncr.23956 · Cited by 118
Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case–control studies
Cancer), T. A. C. S. (., Faber, M. T., Chenevix‐Trench, G., Kjær, S. K., Dehlendorff, C., Chang‐Claude, J., Andersen, K. K., Høgdall, E. V. S., Webb, P. M., Jordan, S. J., et al. (2013) · Cancer Causes & Control · doi:10.1007/s10552-013-0174-4 · Cited by 117
Self-citationProspective Study of Talc Use and Ovarian Cancer
Gertig, D. M., Hunter, D. J., Cramer, D. W., Colditz, G. A., Speizer, F. E., Willett, W. C., & Hankinson, S. E. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.3.249 · Cited by 116
Epithelial ovarian cancer: testing the 'androgens hypothesis'
Olsen, C. M., Green, A. C., Nagle, C. M., Jordan, S. J., Whiteman, D. C., Bain, C., Webb, P. M., & on behalf of the Australian Cancer Study Group (Ovarian Cancer) and the Australian Ovarian Cancer Study Group (2008) · Endocrine Related Cancer · doi:10.1677/erc-08-0075 · Cited by 113
Self-citationDiabetes Mellitus and Ovarian Cancer Risk
Lee, J., Jeon, I., Kim, J., Song, Y. S., Yoon, J.-M., & Park, S. M. (2013) · International Journal of Gynecological Cancer · doi:10.1097/igc.0b013e31828189b2 · Cited by 106
Genetics and ovarian carcinoma.
Lynch, H. T., Casey, M. J., Lynch, J. A., White, T., & Godwin, A. K. (1998) · PubMed · Cited by 106
Genital Powder Use and Risk of Ovarian Cancer: A Pooled Analysis of 8,525 Cases and 9,859 Controls
Terry, K. L., Karageorgi, S., Shvetsov, Y. B., Merritt, M. A., Lurie, G., Thompson, P. J., Carney, M. E., Weber, R. P., Akushevich, L., Lo-Ciganic, W.-H., et al. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0037 · Cited by 104
Self-citationAdult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study
Dixon‐Suen, S. C., Nagle, C. M., Thrift, A. P., Pharoah, P. D. P., Pearce, C. L., Zheng, W., Painter, J. N., AOCS Group & Australian Cancer Study (Ovarian Cancer), Chenevix‐Trench, G., Fasching, P. A., et al. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw158 · Cited by 103
Predictors of Ovarian Steroid Secretion in Reproductive-Age Women
Westhoff, C. L., Gentile, G. P., Lee, J. S., Zacur, H. A., & Helbig, D. W. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008939 · Cited by 99
Jervis, S., Song, H., Lee, A., Dicks, E., Tyrer, J. P., Harrington, P. A., Easton, D. F., Jacobs, I. J., Pharoah, P. D. P., & Antoniou, A. C. (2013) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2013-102015 · Cited by 93
Rasmussen, C. B., Kjær, S. K., Albieri, V., Bandera, E. V., Doherty, J. A., Høgdall, E. V. S., Webb, P. M., Jordan, S. J., Rossing, M. A., Wicklund, K. G., et al. (2016) · American Journal of Epidemiology · doi:10.1093/aje/kww161 · Cited by 91
Self-citationRole of physical activity and sport in oncology
Bouillet, T., Bigard, X. A., Brami, C., Chouahnia, K., Copel, L., Dauchy, S., Delcambre, C., Descotes, J.-M., Joly, F., Lepeu, G., et al. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2014.12.012 · Cited by 89
Brunner, R. L., Wactawski‐Wende, J., Caan, B. J., Cochrane, B. B., Chlebowski, R. T., Gass, M. L. S., Jacobs, E. T., LaCroix, A. Z., Lane, D. S., Larson, J. C., et al. (2011) · Nutrition and Cancer · doi:10.1080/01635581.2011.594208 · Cited by 86
Factors influencing ovulation and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
Kotsopoulos, J., Lubiński, J., Gronwald, J., Cybulski, C., Demsky, R., Neuhausen, S. L., Kim‐Sing, C., Tung, N., Friedman, S., Senter, L. A., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.29386 · Cited by 74
Low-dose aspirin use and the risk of ovarian cancer in Denmark
Baandrup, L., Kjær, S. K., Olsen, J. H., Dehlendorff, C., & Friis, S. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu578 · Cited by 71
In vitro fertilization is associated with an increased risk of borderline ovarian tumours
Stewart, L. M., Holman, C. D. J., Finn, J., Preen, D. B., & Hart, R. J. (2013) · Gynecologic Oncology · doi:10.1016/j.ygyno.2013.01.027 · Cited by 70
Trabert, B. L., Lamb, E. J., Scoccia, B., Moghissi, K. S., Westhoff, C. L., Niwa, S., & Brinton, L. A. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.08.008 · Cited by 68
Depot medroxyprogesterone acetate and epithelial ovarian cancer: a multicentre case–control study
Wilailak, S., Vipupinyo, C., Suraseranivong, V., Chotivanich, K., Kietpeerakool, C., Tanapat, Y., Therasakvichya, S., Hamontri, S., Linasmita, V., Bunyapipat, S., et al. (2012) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2012.03298.x · Cited by 65
Alcohol intake and ovarian cancer risk: a pooled analysis of 10 cohort studies
Genkinger, J. M., Hunter, D. J., Spiegelman, D. L., Anderson, K. E., Buring, J. E., Freudenheim, J. L., Goldbohm, R. A., Harnack, L., Hankinson, S. E., Larsson, S. C., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603020 · Cited by 63
Multiple Births and Risk of Epithelial Ovarian Cancer
Whiteman, D. C., Murphy, M. F., Cook, L. S., Cramer, D. W., Hartge, P., Marchbanks, P. A., Nasca, P. C., Ness, R. B., Purdie, D. M., & Risch, H. A. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.14.1172 · Cited by 63
Ji, J., Sundquist, J., & Sundquist, K. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.544 · Cited by 60
Cannioto, R. A., & Moysich, K. B. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.03.016 · Cited by 52
Cannioto, R. A., LaMonte, M. J., Risch, H. A., Hong, C., Sucheston-Campbell, L. E., Eng, K. H., Szender, J. B., Chang‐Claude, J., Schmalfeldt, B., Klapdor, R., et al. (2016) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-1330 · Cited by 51
Self-citationPerineal Powder Use and Risk of Ovarian Cancer
Houghton, S. C., Reeves, K. W., Hankinson, S. E., Crawford, L., Lane, D. S., Wactawski‐Wende, J., Thomson, C. A., Ockene, J., & Sturgeon, S. R. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju208 · Cited by 50
Au‐Yeung, G., Webb, P. M., DeFazio, A., Fereday, S., Bressel, M., & Mileshkin, L. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.01.030 · Cited by 49
Self-citationChenevix‐Trench, G., Cannioto, R. A., LaMonte, M. J., Kelemen, L. E., Risch, H. A., Eng, K. H., Minlikeeva, A. N., Hong, C., Szender, J. B., Sucheston-Campbell, L. E., et al. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.153 · Cited by 48
Self-citationSoini, T., Hurskainen, R., Grénman, S., Maenpaa, J. U., Paavonen, J. A., & Pukkala, E. (2016) · Acta Oncologica · doi:10.1080/0284186x.2016.1175660 · Cited by 47
Epithelial ovarian cancer risk by invasiveness and cell type in the Central Valley of California
Mills, P. K., Riordan, D. G., & Cress, R. D. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.07.012 · Cited by 46
Chenevix‐Trench, G., Kelemen, L. E., Bandera, E. V., Terry, K. L., Rossing, M. A., Brinton, L. A., Doherty, J. A., Ness, R. B., Kjær, S. K., Chang-Claude, J. C., et al. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-28 · Cited by 44
Self-citationMerritt, M. A., Tzoulaki, I., van den Brandt, P. A., Schouten, L. J., Tsilidis, K. K., Weiderpass, E., Patel, C. J., Tjønneland, A. M., Hansen, L., Overvad, K., et al. (2015) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.118588 · Cited by 42
Hildebrand, J. S., Gapstur, S. M., Gaudet, M. M., et al. (2015) · Cancer Causes & Control · doi:10.1007/s10552-015-0656-7 · Cited by 41
Tokuoka, S., Kawai, K., Shimizu, Y., Inai, K., Ohe, K., Fujikura, T., & Kato, H. (1987) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/79.1.47 · Cited by 40
Prognostic implications of reproductive and lifestyle factors in ovarian cancer
Poole, E. M., Konstantinopoulos, P. A., & Terry, K. L. (2016) · Gynecologic Oncology · doi:10.1016/j.ygyno.2016.05.014 · Cited by 40
Paracetamol use and risk of ovarian cancer: a meta‐analysis
Bonovas, S., Filioussi, K., & Sitaras, N. M. (2005) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2005.02526.x · Cited by 33
Dairy food and nutrient intake in different life periods in relation to risk of ovarian cancer
Merritt, M. A., Poole, E. M., Hankinson, S. E., Willett, W. C., & Tworoger, S. S. (2014) · Cancer Causes & Control · doi:10.1007/s10552-014-0381-7 · Cited by 21
Prescription Use of Paracetamol and Risk for Ovarian Cancer in Denmark
Baandrup, L., Friis, S., Dehlendorff, C., Andersen, K. K., Olsen, J. H., & Kjær, S. K. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju111 · Cited by 18
Chen, H.-F., Chang, Y., Ko, M.-C., & Li, C. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.07.001 · Cited by 16
Cited by
High-Grade Serous Ovarian Cancer: Basic Sciences, Clinical and Therapeutic Standpoints
Lisio, M.-A., Fu, L., Goyeneche, A., Gao, Z.-H., & Telleria, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040952 · Cited by 680
Single-Cell Transcriptomic Atlas of Primate Ovarian Aging
Wang, S., Zheng, Y., Li, J., Yu, Y., Zhang, W., Song, M., Liu, Z., Min, Z., Hu, H., Jing, Y., et al. (2020) · Cell · doi:10.1016/j.cell.2020.01.009 · Cited by 588
Global epidemiology of epithelial ovarian cancer
Webb, P. M., & Jordan, S. J. (2024) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-024-00881-3 · Cited by 571
Self-citationZhou, J., Jiang, Y., Chen, H., Wu, Y., & Zhang, L. (2020) · Cell Proliferation · doi:10.1111/cpr.12739 · Cited by 322
RetractedWorldwide Burden, Risk Factors, and Temporal Trends of Ovarian Cancer: A Global Study
Huang, J., Chan, W. C., Ngai, C. H., Lok, V., Zhang, L., Lucero-Prisno, D. E., Xu, W., Zheng, Z.-J., Elcarte, E., Withers, M., et al. (2022) · Cancers · doi:10.3390/cancers14092230 · Cited by 316
Metadata
- Authors
- Webb, P. M., & Jordan, S. J.
- Venue
- Best Practice & Research Clinical Obstetrics & Gynaecology
- Publisher
- Elsevier BV
- Published
- 2017-05
- Volume
- 41
- Pages
- 3-14
- ISSN
- 1521-6934 (ISSN-L)
- OpenAlex
- W2529607059
- Cited by
- 995
- References
- 82
- FWCI
- 42.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.